The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trialJoseph J. Eron, Mark S. Shaefer, Joseph Gathe et al.|The Lancet|2006Cited by 343